Navigation Links
Insomnia: A No-Drug Solution?
Date:12/12/2011

LIEGE, Belgium, December 12, 2011 /PRNewswire/ --

The peer review « BMC Neurology » has published the results of a clinical trial demonstrating the sedative action of the Cefaly® medical device.  

The recent publication, whose abstract is available from the US National Libretry of Medecine (PubMed), reports the results of the HYPNOS I trial.

http://www.ncbi.nlm.nih.gov/pubmed/22035386

The results show, in a statistically highly significant manner using four clinical measurement methods, a pronounced reduction in vigilance induced by the action of the Cefaly® Hypnos medical device, by comparison to a placebo.

This sedative action on the central nervous system is observed after application for 12 minutes in 83% of individuals whose mean increase in tiredness was of 73%.

The Cefaly® is an innovative medical device protected by a series of patents. It is the first external cranial neurostimulation device. It is currently used to treat migraine and headaches and offers the best safety efficacy ratio by comparison to conventional prophylactic drugs.

Numerous patients have reported a tendency to fall asleep when using the Cefaly®. This phenomenon has also been observed during tests or demonstrations. A clinical trial based on strict scientific standards was therefore undertaken to ascertain the veracity of these initial empirical observations. The sedative action demonstrated by the clinical trial is achieved only using certain specific neurostimulation parameters.

The Cefaly Hypnos version is available as a relaxation method for individuals in states of stress or hyperarousal. It should help certain insomniacs achieve sleep more readily. 

http://www.cefaly-insomnie.com/en

http://www.youtube.com/watch?v=I9uTOZTzIZc

http://www.biomedcentral.com/1471-2377/11/135/abstract


'/>"/>
SOURCE STX-Med
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Budget Solution? Modernizing Medicaid Pharmacy Could Save Florida $473 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)...  True Health, a leader in integrated diagnostics ... National Breast Cancer Awareness month to educate doctors ... Research recently published in ... than 10 million American women are at significant ... BRCA2 and have not had testing. These mutations can ...
(Date:10/10/2017)... --  West Pharmaceutical Services, Inc. (NYSE: WST), a ... today shared the results of a study highlighting the ... administration of polio vaccines. The study results were presented ... by Dr. Ondrej Mach , Clinical Trials and ... and recently published in the journal Vaccine. i ...
(Date:10/4/2017)... Oct. 4, 2017  South Korean-based healthcare product Development ... aide "cprCUBE" on Kickstarter. The device will educate the ... arrests with better efficiency compared to the dated and ... feedback on efficacy of the compression for a more ... a goal to raise $5,000. ...
Breaking Medicine Technology:
(Date:10/13/2017)... ... ... “The Journey: From the Mountains to the Mission Field”: the story of a ... “The Journey: From the Mountains to the Mission Field” is the creation of published ... all ages and currently teaches a class of ladies at her church, which she ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... IsoComforter, Inc. ... products, announced today the introduction of an innovative new design of the shoulder pad. ... so you get maximum comfort while controlling your pain while using cold therapy. By ...
(Date:10/12/2017)... (PRWEB) , ... October 12, 2017 , ... ... drug delivery system that we intend to develop to enable prevention of a ... lead to severe hearing loss, especially in pediatric patients. For cisplatin, hearing loss ...
(Date:10/12/2017)... ... 12, 2017 , ... Leading pediatric oncology experts at Children’s National Health ... Congress of the International Society of Paediatric Oncology (SIOP) Oct. 12-15. Chaired ... Cancer and Blood Disorders at Children’s National, and Stephen P. Hunger, M.D., Chief ...
Breaking Medicine News(10 mins):